Log in to the Aetna Health app First time with us? Let’s get you to the right place It’s so nice to meet you. To start your journey with us, choose the audience that best fits you. Medicare Get to know your Medicare plan or explore plans with added benefits and services for you...
If so, you may be eligible for a Medicare plan, which is a type of health insurance that covers people 65 and older. Medicare also covers certain disabilities in people under the age of 65. To find out if you’re eligible for Medicare, use this link. For those deemed eligible, there ...
Precertification of ipilimumab (Yervoy) is required of all Aetna participating providers and members in applicable plan designs. For precertification of ipilimumab (Yervoy), call (866) 752-7021 or fax (888) 267-3277. For Statement of Medical Necessity (SMN) precertification forms, see Specialty ...
This Clinical Policy Bulletin addresses botulinum toxin for commercial medical plans. For Medicare criteria, seeMedicare Part B Criteria. Note: Requires Precertification: Precertification of botulinum toxin (Botox [onabotulinumtoxinA]; Daxxify [daxibotulinumtoxinA-lanm], Dysport [abobotulinumtoxinA]; ...
Aetna's HMO plans do not consider AFOs and any related addition medically necessary when used solely for the treatment of edema and/or for the prevention or treatment of a heel pressure ulcer in ambulatory patients, as Medicare does not consider AFO's medically necessary for these indications. ...
Centers for Medicare and Medicaid Services (CMS). National Coverage Determination (NCD) for human tumor stem cell drug sensitivity assays (190.7). Baltimore, MD: CMS; July 1996. Chao SY, Chiang JH, Huang AM, Chang WS. An integrative approach to identifying cancer chemoresistance-associated pathwa...
Aetna follows Medicare rules in considering osseointegrated implants, such as implantable BAHAs and temporal bone stimulators, as prosthetics. Medicare considers as prosthetics "osseointegrated implants, i.e., devices implanted in the skull that replace the function of the middle ear and provide mechan...
This Clinical Policy Bulletin addresses ustekinumab (Stelara) for commercial medical plans. For Medicare criteria, see Medicare Part B Criteria.Note: Requires Precertification:Precertification of ustekinumab (Stelara) administered by a healthcare provider is required of all Aetna participating providers and...
For Medicare criteria, see Medicare Part B Criteria. Note: Requires Precertification: Precertification of bevacizumab (Avastin), bevacizumab-maly (Alymsys), bevacizumab-tnjn (Avzivi), bevacizumab-awwb (Mvasi), bevacizumab-adcd (Vegzelma), and bevacizumab-bvzr (Zirabev), for oncology indications ...